Senators Question Califf, the F.D.A. Nominee, on Opioid Crisis and Pandemic Response
A Senate panel hearing on Tuesday signaled that Dr. Robert Califf, who briefly led the agency during the Obama administration, had some bipartisan support.
Can Eye Drops Replace Reading Glasses?
Vuity, a once-a-day treatment that can help users see up close without affecting their long-range vision, went on the market Thursday after being approved by the F.D.A. in October.
Pfizer Says Its Covid Pill, Paxlovid, Will Protect Against Severe Disease
The company said the pill, Paxlovid, reduced the risk of hospitalization and death by 89 percent if given within three days of the onset of symptoms.
Firms Push for Over-the-Counter Access to Birth-Control Pills
Two drug makers have been mired for years in the pre-application phase of getting F.D.A. approval for over-the-counter use.
Merck’s Covid Pill Might Pose Risks for Pregnant Women
Some laboratory studies suggest that molnupiravir can insert errors in DNA, which could in theory harm a developing fetus, sperm cells or children.
Coronavirus Briefing: What Happened Today
Pfizer and BioNTech say booster shots offer strong protection against Omicron.
F.D.A. Authorizes AstraZeneca Drug for People With Immune Problems
The antibody drug, Evusheld, was found to be strongly effective in preventing Covid in a clinical trial that enrolled mostly those at high risk.
Los nuevos antivirales para la covid ofrecen esperanza frente a la variante ómicron
Merck y Pfizer están por presentar sus pastillas de prescripción para tratar la COVID-19. Vienen más fármacos en camino.
Los nuevos antivirales para la covid ofrecen esperanza frente a la variante ómicron
Merck y Pfizer están por presentar sus pastillas de prescripción para tratar la COVID-19. Vienen más fármacos en camino.
Elizabeth Holmes returns to the stand on Tuesday.
Prosecutors have shown personal documents like text messages and notes that Ms. Holmes wrote and have emphasized that she was ultimately responsible for the problems at Theranos.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.